Apixaban Prophylaxis Fails to Reduce Clots in Pediatric ALL

[MEDPAGE TODAY]( Oncology Update Tuesday, November 21, 2023 [Apixaban Prophylaxis Fails to Reduce Clots in Pediatric ALL]( [Alteplase Not Harmful in NOAC Users, Even in a More Bleeding-Prone Cohort]( [Nudging Parents Plus Auditing Providers Increased HPV Vaccine Uptake in Tweens]( ADVERTISEMENT Exclusives & Features [Doctors, Scientists Boycott Journal for Publishing 'Sadistic' Animal Research]( [What to Know About Ongoing Eye Drop Recalls]( [Why It's So Tough to Reduce Unnecessary Medical Care]( [What role does the nervous system play in cancer? Finding out may mean beating the disease.]( Understanding the interplay between cancer tumors and the nervous system may be essential for winning the war on cancer, researchers say. [READ MORE]( [England To ‘Eradicate’ Cervical Cancer By 2040]( The country will increase access to vaccination and screening in a push to make it one of the first the world to "eradicate" the disease. [READ MORE]( [Capturing evolving definitions of 12 select rare CNS tumors: a timely report from CBTRUS and NCI-CONNECT.]( PURPOSE: Incidence, prevalence, and survival are population-based statistics describing cancer burden. The National Cancer Institute's (NCI) Comprehensive Oncology Network Evaluating Rare CNS Tumors... [READ MORE]( [ASO Practice Guidelines Series: Management of Resectable, Borderline Resectable, and Locally Advanced Pancreas Cancer.]( Pancreatic adenocarcinoma is an aggressive disease marked by high rates of both local and distant failure. In the minority of patients with potentially resectable disease, multimodal treatment... [READ MORE]( [Morphological diversity of cancer cells predicts prognosis across tumor types.]( BACKGROUND: Intratumor heterogeneity drives disease progression and treatment resistance, which can lead to poor patient outcomes. Here, we present a computational approach for quantification of... [READ MORE]( [A Property of Everyday Health group]( © 2023 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_Spec_Oncology_Update?xid=nl_mpt_Oncology_update_2023-11-21&eun=g1020308d0r) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 114 5th Avenue, 15th Floor New York, NY 10011